Small/Middle tier cities and County Lung Cancer Quality Improvement Project (QIP) study

Study identifier:D5161L00048

ClinicalTrials.gov identifier:NCT06494241

EudraCT identifier:N/A

CTIS identifier:N/A

Will Be Recruiting

Official Title

A multi-Center study to evaluate the guideline education of oncology departments in Small/Middle tier cities and County hospitals for diagnosis and treatment improvement in patients with Metastatic Non-small Cell Lung Cancer

Medical condition

Carcinoma, Non-Small-Cell Lung, Lung Diseases

Phase

Phase 4

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

1000

Study type

Observational

Age

18 Years - n/a

Date

Study Start Date: 28 Nov 2024
Estimated Primary Completion Date: 28 Nov 2027
Estimated Study Completion Date: 28 Nov 2027

Study design

Allocation: Non-randomized
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Oct 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria